Cargando…
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery
Recent positive clinical results in cancer immunotherapy point to the potential of immune-based strategies to provide effective treatment of a variety of cancers. In some patients, the responses to cancer immunotherapy are durable, dramatically extending survival. Extensive research efforts are bein...
Autores principales: | Bedognetti, Davide, Balwit, James M, Wang, Ena, Disis, Mary L, Britten, Cedrik M, Delogu, Lucia G, Tomei, Sara, Fox, Bernard A, Gajewski, Thomas F, Marincola, Francesco M, Butterfield, Lisa H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189883/ https://www.ncbi.nlm.nih.gov/pubmed/21929757 http://dx.doi.org/10.1186/1479-5876-9-155 |
Ejemplares similares
-
Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force
por: Butterfield, Lisa H, et al.
Publicado: (2010) -
The iSBTc/SITC primer on tumor immunology and biological therapy of cancer: a summary of the 2010 program
por: Balwit, James M, et al.
Publicado: (2011) -
A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
por: Butterfield, Lisa H, et al.
Publicado: (2008) -
Preamble to the 2015 SITC immunotherapy biomarkers taskforce
por: Butterfield, Lisa H, et al.
Publicado: (2015) -
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery
por: Hu-Lieskovan, Siwen, et al.
Publicado: (2020)